Day: May 9, 2024

– Archway Nursing Facility and Related Property to be Sold for $6.75 Million – Greenwood Village, Colorado, May 09, 2024 (GLOBE NEWSWIRE) — Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) announced that its wholly-owned subsidiary, Goodwill Hunting, LLC (the “Seller”), has executed and delivered a definitive Purchase and Sale Agreement (the “PSA”) to sell certain real property located in Macon, Bibb County, Georgia, including the skilled nursing facility known as Archway Transitional Care Center1 (collectively, “the Archway Property”). Pursuant to the PSA, Bibb County Holdings II, LLC (the “Purchaser”) has agreed to purchase the Archway Property for $6.75 million, subject to certain prorations, holdbacks, and adjustments customary in transactions of this nature. The Seller and...

SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) — Adeia Inc. (Nasdaq: ADEA), the company whose patented innovations shape the way the world explores and experiences entertainment, today announced that Panasonic Entertainment & Communication Co., Ltd. (“Panasonic”), a global provider of services and products, has agreed to a multi-year renewal of its license for Adeia’s media intellectual property (IP) portfolio. As a leading manufacturer of smart and connected TVs and a wide range of consumer electronics, Panasonic has played an iconic role in offering customers around the world access to innovative digital and entertainment technologies. “Panasonic is a touchstone brand for an extensive lineup of consumer electronics, including smart and connected TVs,” said Dr. Mark Kokes, Adeia’s chief licensing...

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) — Dorel Industries, Inc. (TSX: DII.B, DII.A)CONFERENCE CALL:OPEN TO: Analysts, investors and all interested partiesDATE: Friday, May 10, 2024TIME: 1:00 PM Eastern TimeCALL: 1-800-319-4610   THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKETS OPEN THE SAME DAY THROUGH GLOBENEWSWIRE. Please dial in 15 minutes before the conference begins. If you are unable to call in at this time, you may access a recording of the meeting by calling 1-800-319-6413 and entering the passcode 0766 on your phone. This recording will be available on Friday, May 10, 2024 as of 4:30 PM until 11:59 PM on Friday, May 17, 2024. MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT THE ANALYST PERSONALLY FOR PERMISSION. NOTE TO FIRST-TIME ANALYSTS: Please contact Rick Leckner at Saint Victor Investments...

HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar on May 23, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Nexalin CEO Mark White, who will share insight into the Company’s growing clinical data supporting its non-invasive, frequency-based deep brain stimulation device, as well as progress on its new Gen-3 HALO™ Clarity & Virtual Clinic model. A live Q&A session with White will follow the presentation. To register for the free webinar, please visit: https://redchip.zoom.us/webinar/register/WN_kFIw9RFmQnqrPAX03eC20w#/registration Questions can be pre-submitted to NXL@redchip.com or online during the live event. About Nexalin Technology, Inc. Nexalin designs and develops...

The rescheduled Earnings Conference Call is to be Held on Friday, May 10, 2024 at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing / Hong Kong) NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), which operates KylinCloud, a livestreaming ecommerce business in China with access to 800,000+ hosts and influencers, today announced that it will conduct a conference call at 8:00 am Eastern Time on Friday, May 10, 2024, to discuss its second half and full year financial results for its fiscal year ended December 31, 2023. The Second Half and Fiscal Year End 2023 Earnings Press Release will be available prior to the Company’s Earnings Conference Call at: https://www.nasdaq.com/market-activity/stocks/aehl/press-releases. To...

Completed enrollment in izokibep Phase 3 trial in hidradenitis suppurativa and enrollment completion in Phase 2b/3 trial in uveitis expected this month; top line data for both trials now expected by end of third and fourth quarter of 2024, respectively Reported positive proof-of-concept for lonigutamab in thyroid eye disease patients and positive top-line Phase 2b/3 data for izokibep in psoriatic arthritis Cash, cash equivalents, and short-term marketable securities at March 31, 2024 of $678.5 million Company also announced changes to leadership team LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today provided an update on various corporate milestones. “Our top priority...

ST. GALLEN, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company, today announced that Carsten Koerl, Chief Executive Officer, will participate in the J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference at the Westin Boston Seaport District Hotel on Tuesday, May 21, 2024. Mr. Koerl will participate in a fireside chat at 8:10 a.m. EST that morning and that will be webcast live on https://investors.sportradar.com. Please contact your J.P. Morgan sales representative to register for the conference and to request a meeting with Sportradar management. About SportradarSportradar Group AG (NASDAQ: SRAD), founded in 2001, is a leading global sports technology company creating immersive experiences for sports...

WARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, announced today that the management team will participate in The Citizens JMP Life Sciences Conference on May 13, 2024. The Aquestive management team will hold a fireside chat on May 13 at 11:30 am ET and will host investor meetings. A webcast of the fireside chat will be available on the “Events and Presentation” page of the Investors section of the Company’s website. A replay of the webcast will be available for 30 days following the event. For more information, please visit investors.aquestive.com. About AquestiveAquestive is a pharmaceutical company advancing medicines...

Bio-Equity Europe 2024 Asebio Investor Day 2024 RSC Hot Topics: Covalent Drug Discovery Foro Medcap BME 2024MADRID, Spain and CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give an update on corporate progress at several international events in May. Oryzon will attend Bio-Equity Europe 2024, which will be held at the Kursaal Elkargunea Center in San Sebastián (Spain) on May 12-14. The company will provide a corporate update on May 13 at 15:15 CET and will hold one-on-one meetings with global investors and pharmaceutical companies. Click on the link for more info about Bio-Equity Europe 2024 Oryzon has...

BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the B. Riley 24th Annual Institutional Investor Conference, which is being held May 22-23, 2024 at the Beverly Hilton Hotel in Beverly Hills, California. Derek Dubner, Chief Executive Officer, and Dan MacLachlan, Chief Financial Officer, are scheduled to participate in an analyst-led discussion on Wednesday, May 22, 2024, at 9:00 a.m. PT, in addition to hosting one-on-one meetings with interested investors. Investors wishing to schedule a one-on-one meeting should contact their B. Riley representative. About red violet® At red violet, we build proprietary technologies and apply analytical capabilities to deliver identity intelligence. Our technology powers...